PRP and Stem Cell Alopecia Treatment Companies and Development Strategy

PRP and Stem Cell Alopecia Treatment Market Companies with Latest Offerings

Latest Offerings:

Stemson Therapeutics

Headquarters: San Diego, U.S.
Offerings: Specializes in iPSC-derived stem cell follicle engineering for hair regeneration.

RepliCel Life Sciences

Headquarters: Vancouver, Canada
Offerings: Focuses on autologous cell therapy for hair loss treatment.

Regen Lab SA

Headquarters: Le Mont-sur-Lausanne, Switzerland
Offerings: Develops PRP and cell preparation medical devices to support regenerative treatments.

EmCyte Corporation

Headquarters: Fort Myers, U.S.
Offerings: Provides high-concentration PRP solutions for hair restoration.

Arthrex, Inc.

Headquarters: Naples, U.S.
Offerings: Offers autologous conditioned plasma and regenerative tools for hair and tissue repair.

HairClone Ltd.

Headquarters: Manchester, UK
Offerings: Conducts follicle banking and cell multiplication research services for future hair restoration therapies.

Kerastem Technologies

Headquarters: Solana Beach, U.S.
Offerings: Specializes in adipose-derived stem cell therapy for hair regeneration.

Eclipse MedCorp

Headquarters: The Colony, U.S.
Offerings: Supplies PRP kits and microneedling equipment for hair treatment procedures.

Bosley Medical

Headquarters: Beverly Hills, U.S.
Offerings: Provides PRP and cell-based hair restoration solutions through clinical services.

Pelage Pharmaceuticals

Headquarters: Los Angeles, U.S.
Offerings: Develops small molecule stem cell activators to stimulate hair follicle renewal.

Market Value Chain Analysis

R&D

• The R&D of the PRP and stem cell alopecia treatment focuses on the stem cell reactivation and autologous cell multiplication for hair follicle regeneration.
• Key players: Stemson Therapeutics, Pelage Pharmaceuticals.

Clinical Trials and Regulatory Approvals

• The hair density and shaft thickness were measured in the clinical trials and regulatory approval of the PRP and stem cell alopecia treatment.
• Key players: RepliCel, Stemson Therapeutics.

Patient Support and Services

• Post-procedure recovery kits, financing programs, and personalized scalp diagnostics are provided in the patient support and services of PRP and stem cell alopecia treatment.
• Key players: Bosley Medical, Bernstein Medical.

PRP and Stem Cell Alopecia Treatment Market Growth 2026-2035

The global PRP and stem cell alopecia treatment market size was estimated at USD 489.27 million in 2025 and is predicted to increase from USD 515.93 million in 2026 to approximately USD 831.79 million by 2035, expanding at a CAGR of 5.45% from 2026 to 2035.

Recent Developments in the Market

• In December 2025, new preclinical data of ABS-201 were revealed by the Absci Corporation. As per the data released, the product demonstrated effective regeneration of the stem cells and stimulation of other key growth modulators, promoting hair growth.
• In October 2025, a successful closing of a $120 million Series B financing round was announced by Pelage Pharmaceuticals, which is a clinical-stage regenerative medicine biotechnology company. To support the advancement of the PP405, a topical small molecule developed to treat hair loss in males and females by reactivating dormant hair follicle stem cells, this funding will be utilized.
• In October 2025, a total of $150 million in a series C financing round was secured by Veradermics, which will be utilized to support the ongoing phase 3 clinical trial of its lead program VDPHL01.

Partner with our experts to explore the PRP and Stem Cell Alopecia Treatment Market at sales@towardshealthcare.com